Drug Trial News

RSS

Phase III data on Safinamide in Parkinson's disease

Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.

4 May 2007

Negative pressure wound therapy for pediatric patients

Negative pressure wound therapy is a new innovation in treating severe and complex wounds in children that decreases the need for frequent and stressful dressing changes.

4 May 2007

LigoCyte Pharmaceuticals presents data showing that immunization with their influenza H1N1-VLP formulation resulted in 100% protection from H1N1 and H3N2

LigoCyte Pharmaceuticals has presented preclinical data showing that immunization with their influenza virus-like particles (VLPs) induced heterosubtypic protection in a virus challenge study.

4 May 2007

HCV patients survival after liver transplantation is not improving

For liver transplant recipients without hepatitis C (HCV), survival has improved over time.

4 May 2007

Mesoblast receives FDA clearance for heart attack stem cell trial

Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks.

4 May 2007

Nutritional benefits of egg consumption

Nine studies presented at the Experimental Biology 2007 meeting support the growing body of research on the nutritional benefits of egg consumption, including its promotion of weight loss and its role in providing choline, an essential nutrient often lacking in the diet that promotes brain and memory development and function.

4 May 2007

Binge drinking decreases brain volume

Drinking heavy amounts of alcohol over a long period of time may decrease brain volume, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Amateur boxing and brain damage

Blows to the head in amateur boxing appear to cause brain damage, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.

4 May 2007

Statins reduce risk of stroke and heart attack

People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 , May 5, 2007.

4 May 2007

Novel respiratory antibiotic Cethromycin, shown to be effective against Anthrax

Advanced Life Sciences Holdings has announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection.

4 May 2007

Cause of gender differences in high blood pressure and related kidney disease

While men and women both get high blood pressure and related kidney disease, the path to get there is shorter, steeper and just different for men, researchers say.

4 May 2007

BioMarin starts phase 2a study of 6R-BH4 in sickle cell disease

BioMarin Pharmaceutical has announced that the first patient has initiated treatment in the Phase 2a clinical study of 6R-BH4 (sapropterin dihydrochloride) for the treatment of sickle cell disease (SCD).

4 May 2007

Reclast found to cause abnormal heart rhythms

An osteoporosis drug with the potential to cut the risk of spine fractures by 70 percent and the chance of hip fractures by 41 percent, has been found to have an adverse side effect on some women.

3 May 2007

Use of antithrombotics means more intracerebral haemorrhagic stroke deaths in over 75s

A study suggests that the number of pensioners over 75 dying from intracerebral haemorrhagic stroke has increased in the last 25 years due to use of antithrombotic drugs.

2 May 2007

Strong link between domestic violence and asthma

The link between environmental exposures and asthma has been clearly described, but a new study from researchers at the Harvard School of Public Health (HSPH) finds a strong association between domestic violence and asthma.

2 May 2007

Serious illness among children with sickle cell disease reduced with pneumococcal conjugate vaccine

A vaccine introduced in 2000 has reduced by more than 90 percent the rate of a serious bacterial illness among young children with sickle cell disease (SCD), who are particularly susceptible to it, according to a new study that appears in the June 1 issue of Clinical Infectious Diseases and currently is available online.

2 May 2007

Recommended doses of ginseng, ginko biloba do not interfere with drug absorption

Recent findings that the widely-used herbal supplement Saint John's wort could dramatically affect the absorption and metabolism of many prescription and non-prescription drugs raised concerns that other popular herbal supplements might cause similar changes, thus significantly altering drugs, therapeutic or toxic effects.

2 May 2007

Racial disparities in treatment of patients with cirrhosis and complications of portal hypertension

African-American and Hispanic patients hospitalized for complications of portal hypertension were less likely to undergo a palliative shunt, prompt endoscopy, or liver transplantation compared to white patients, according to a new study in the May issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

2 May 2007

Hurricanes, infectious disease and public health

In the first study ever to evaluate urban sediment after Hurricanes Katrina and Rita, scientists from the University of Miami Rosenstiel School of Marine & Atmospheric Science have published their findings in this week's issue of the Proceedings of the National Academy of Sciences, pointing to the need for rapid environmental assessments.

2 May 2007

Infliximab fails to improve chronic obstructive pulmonary disease symptoms

A promising anti-inflammatory drug failed to improve symptoms of moderate to severe chronic obstructive pulmonary disease, or COPD, in a large, multi-center trial.

2 May 2007